Media Release: Allianz Celebrates “Unsung Heroes of Sport” who Bridge Social Divides to Create Connection
The role of sports in our society extends beyond just physical activity or competition. Sport teams foster social cohesion by bringing together people from a wide range of backgrounds around a shared passion. Allianz is proud to celebrate the unifying power of sport with the Unity Awards. This initiative shines a light on the everyday champions who use sport to shape values, build character and bridge social and cultural divides. Allianz invites local sports clubs, trainers, teammates or parents to share their personal “unity through sport” story in a video by the end of June. The winners will receive public recognition and financial support to strengthen their community-building efforts.
A recent study by Allianz and the International Olympic Committee (IOC), which surveyed 5,000 people aged 12 to 24 years, and 2,000 parents of 12- to 18-year-olds across 10 countries, showed that sport can provide a vital sense of belonging, joy, and hope. A total of 77% said sports help them to make new friends, 58% feel they belong to a community when playing, while 72% believe in the societal importance of sport.
These insights highlight the importance of supporting grassroots efforts and amateur clubs that acknowledge the power of sport to overcome division and bring people together – the sentiment which the Unity Awards seek to capture. The awards are a new initiative within Allianz’s long-term “Power of Unity” program that aims to overcome division and unite people around a shared cause in an increasingly polarized world.
“Most visibly demonstrated through our long-standing partnership with the Olympic and Paralympic Movements, Allianz strongly believes in the power of sport to unite people, says Global Head of Olympic and Paralympic Program at Allianz, Eike Bürgel. In addition to high-profile global partnerships, Allianz actively supports local sports clubs in its core markets. With the new Unity Awards, we want to celebrate the unsung heroes of sport – often volunteers – who inspire us with their dedication to teaching young people life values and the importance of standing united despite our differences.’’
The Unity Awards build on Allianz’s wide range of long-term partnerships in sports. The leading insurer is a strategic partner of the Olympic and Paralympic Movements and contributed to the successful organization of the Olympic and Paralympic Games Paris 2024. Allianz will also be closely involved in the Olympic and Paralympic Winter Games Milano Cortina 2026 and is promoting safety in bobsled through a partnership with the German Bobsleigh, Luge, and Skeleton Federation. For many years, Allianz has also been a partner of FC Bayern and a sponsor of the men's and women's teams. With the Squared Ball initiative, Allianz helps young female players achieve their financial goals with confidence and know-how, and through the MoveNow program it promotes sports and exercise among young people.
Allianz launched the “Power of Unity” program in November 2024 to help individuals and organizations to engage more constructively in the face of growing polarization worldwide. Through research, thought leadership, learning programs and events, it seeks to promote dialogue and respectful debate, bridge divides by encouraging mutual understanding, and restore trust in societal institutions.
Applying to the Unity Awards
Sports clubs that work towards reducing prejudice, building resilience, and challenging stereotypes by promoting tolerance, are welcome to apply for the Allianz Unity Awards.
How to participate
- Application is open to individuals, teams, and clubs from amateur to professional levels who can demonstrate the use of sport to unite people. Coaches, teammates, club supporters, parents, or volunteers can be nominated or apply themselves.
-
To participate, applicants are invited to submit a short self-made video (under 30 seconds) sharing their personal “unity through sport” story. Entries can be submitted either:
- Through social media using the hashtag #AllianzUnityAwards, or
- Via the Power of Unity content hub.
- The application period runs from June 1-30, 2025.
Further details and information about the application process can be foundhere.
Selection and Recognition
Award recipients will be chosen in multiple categories including coach, teammate, club supporter, and parent. Winners will receive Unity jerseys, recognizing their contributions to fostering inclusion, addressing social challenges, and creating lasting impact through sport.
In addition to public recognition, winners will receive financial support from Allianz’s MoveNow Fund to further their community efforts. This support may take the form of new team jerseys, clubhouse renovations, training workshops, or other needs identified by the recipients.
Selected stories will be featured throughout the campaign in Allianz communications, supported by user-generated content and an influencer campaign in the UK and Germany to extend reach beyond Allianz’s own platforms.
Further Links |
About Allianz
The Allianz Group is one of the world's leading insurers and asset managers with around 128 million* private and corporate customers in nearly 70 countries. Allianz customers benefit from a broad range of personal and corporate insurance services, ranging from property, life and health insurance to assistance services to credit insurance and global business insurance. Allianz is one of the world’s largest investors, managing around 768 billion euros** on behalf of its insurance customers. Furthermore, our asset managers PIMCO and Allianz Global Investors manage about 1.9 trillion euros** of third-party assets. Thanks to our systematic integration of ecological and social criteria in our business processes and investment decisions, we are among the leaders in the insurance industry in the Dow Jones Sustainability Index. In 2024, over 156,000 employees achieved total business volume of 179.8 billion euros and an operating profit of 16.0 billion euros for the group.
* As of December 31, 2024. Including non-consolidated entities with Allianz customers.
** As of March 31, 2025.
Mandatory corporate information: Corporate disclosures
These assessments are, as always, subject to the disclaimer provided below.
Cautionary note regarding forward-looking statements
This document includes forward-looking statements, such as prospects or expectations, that are based on management's current views and assumptions and subject to known and unknown risks and uncertainties. Actual results, performance figures, or events may differ significantly from those expressed or implied in such forward-looking statements.
Deviations may arise due to changes in factors including, but not limited to, the following: (i) the general economic and competitive situation in the Allianz’s core business and core markets, (ii) the performance of financial markets (in particular market volatility, liquidity, and credit events), (iii) adverse publicity, regulatory actions or litigation with respect to the Allianz Group, other well-known companies and the financial services industry generally, (iv) the frequency and severity of insured loss events, including those resulting from natural catastrophes, and the development of loss expenses, (v) mortality and morbidity levels and trends, (vi) persistency levels, (vii) the extent of credit defaults, (viii) interest rate levels, (ix) currency exchange rates, most notably the EUR/USD exchange rate, (x) changes in laws and regulations, including tax regulations, (xi) the impact of acquisitions including related integration issues and reorganization measures, and (xii) the general competitive conditions that, in each individual case, apply at a local, regional, national, and/or global level. Many of these changes can be exacerbated by terrorist activities.
No duty to update
Allianz assumes no obligation to update any information or forward-looking statement contained herein, save for any information we are required to disclose by law.
Privacy Note
Allianz SE is committed to protecting your personal data. Find out more in our privacy statement.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250516701733/en/
Contacts
For further information please contact:
Lauren Day
Tel. +49 89 3800 3345
E-Mail: lauren.day@allianz.com
Florian Amberg
Tel. +49 89 3800 15924
E-Mail: florian.amberg@allianz.com
Heidi Polke
Tel. +49 89 3800 90777
E-Mail: heidi.polke@allianz.com
Patricia Segovia
Tel. +49 89 3800 67589
E-Mail: patricia.segovia@allianz.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Takeda’s Zasocitinib Landmark Phase 3 Plaque Psoriasis Data Show Promise to Deliver Clear Skin in a Once-Daily Pill, Catalyzing a New Era of Treatment18.12.2025 09:00:00 CET | Press Release
Takeda(TSE:4502/NYSE:TAK)today announced positive topline results for the two pivotal Phase 3randomized, multicenter, double-blind, placebo- and active comparator-controlled studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO). The studies demonstrated superiority of zasocitinib compared to placebo for the co-primary endpoints, static Physician Global Assessment (sPGA) 0/1 and Psoriasis Area and Severity Index (PASI) 75, at week 16, with a significantly greater PASI 75 response rate seen as early as week 4 and continuing to increase through week 24. The studies also met all 44 ranked secondary endpoints, including PASI 90, PASI 100 and sPGA 0 against placebo and apremilast, showing the potential of a convenient once-daily pill to deliver complete skin clearance for patients with PsO. “People living with psoriasis continue to seek safe, effective and fast-acting oral therap
DATROWAY ® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press Release
The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Products for Human Use. The application is based on data from the TROPION-Breast02 phase 3 trial presented in a late-breaking proffered paper session at the 2025 European Society for Medical Oncology (#ESMO25) Congress. In the trial, DATROWAY demonstrated statistically significant and clinical
Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press Release
Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution for intravenous infusion. “The new SteQeyma™ autoinjector brings together convenience and practical usability to meet the everyday challenges faced by patients living with chronic inflammatory diseases. The full range of our SteQeyma™ dosage forms and strengths, with the autoinjector now added, provides patients and healthcare professionals with more individualized treatm
Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press Release
Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly three years, while adding a seasoned in-country team spanning operations, support, sales, finance, and leadership to enable rapid integration and future growth. The E
Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press Release
Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which translate into thinner, more discreet and comfortable products. Its high compression capability enables s
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom